USD 9.819.819,223,372,036,855%

Senior Vice President - Corporate Partnerships, Commercial

Mr. George B. Abercrombie is Senior Vice President Corporationrationrate Partnerships Commercial of the Company. Mr. George B. Abercrombie RPh MBA joined Innoviva Inc. in June 2014. Prior to joining Innoviva Mr. Abercrombie served as the President and Chief Executive Officer of HoffmannLa Roche Inc. from 2001 to 2009 where he was responsible for the US and Canadian business divisions. From 1993 to 2001 Mr. Abercrombie worked at Glaxo and its successor companies including as Senior Vice President of Commercial Operations for Glaxo Wellcome Inc. He is the Chairman of the Board of BioCryst Pharmaceuticals Inc. and also serves as a board member of numerous other healthcarerelated organizations including Project Hope and the North Carolina GlaxoSmithKline Foundation

Age: 60 President Since 2014 MBA

650-238-9600 http://www.thrxinc.com

Abercrombie holds an MBA from Harvard Business School and a BS from the University of North Carolina at Chapel Hill, School of Pharmacy.

Management Efficiency

The company has return on total asset (ROA) of 1.82 % which means that it generated profit of $1.82 on every $100 spent on asset. This is way below average.

The company currently holds 744.09 M in liabilities with Debt to Equity (D/E) ratio of 1.09 which is about average as compared to similar companies. Theravance Inc has Current Ratio of 19.44 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Found 2 records

PRESIDENT Since

Entity Summary

Theravance, Inc., a royalty management company, is focused on developing respiratory products. Theravance Inc (THRX) is traded on NASDAQ in USA. It is located in South San Francisco, CA and employs 13 people.